| scholarly article | Q13442814 |
| P356 | DOI | 10.1172/JCI110946 |
| P953 | full work available at URL | https://europepmc.org/articles/PMC1129155 |
| http://www.jci.org/articles/view/110946/files/pdf | ||
| https://europepmc.org/articles/PMC1129155?pdf=render | ||
| P932 | PMC publication ID | 1129155 |
| P698 | PubMed publication ID | 6223940 |
| P5875 | ResearchGate publication ID | 16972209 |
| P2093 | author name string | Z. M. Ruggeri | |
| R. R. Montgomery | |||
| L. De Marco | |||
| R. Bader | |||
| L. Gatti | |||
| P2860 | cites work | The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis | Q29053311 |
| Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril | Q29618344 | ||
| Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity | Q29618557 | ||
| Decreased adhesion of giant (Bernard-Soulier) platelets to subendothelium. Further implications on the role of the von Willebrand factor in hemostasis | Q33463842 | ||
| Platelet membrane defects in Glanzmann's thrombasthenia. Evidence for decreased amounts of two major glycoproteins | Q33483955 | ||
| Studies on human antihemophilic factor. Evidence for a covalently linked subunit structure | Q35199709 | ||
| Diagnosis of Bernard-Soulier syndrome and Glanzmann's thrombasthenia with a monoclonal assay on whole blood. | Q35203348 | ||
| Glanzmann thrombasthenia: deficient binding of von Willebrand factor to thrombin-stimulated platelets | Q36314768 | ||
| Thrombin-induced exposure and prostacyclin inhibition of the receptor for factor VIII/von Willebrand factor on human platelets | Q36983829 | ||
| Analysis of the glycoprotein and protein composition of Bernard-Soulier platelets by single and two-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis | Q36998885 | ||
| Demonstration and characterization of specific binding sites for factor VIII/von Willebrand factor on human platelets | Q37037311 | ||
| von Willebrand's disease antigen II. A new plasma and platelet antigen deficient in severe von Willebrand's disease | Q37054131 | ||
| Absence of the platelet receptor for drug-dependent antibodies in the Bernard-Soulier syndrome | Q40688611 | ||
| Human platelets possess an inducible and saturable receptor specific for fibrinogen | Q41629256 | ||
| HIGH-POTENCY ANTIHAEMOPHILIC FACTOR CONCENTRATE PREPARED FROM CRYOGLOBULIN PRECIPITATE. | Q45868038 | ||
| Adenosine diphosphate induces binding of von Willebrand factor to human platelets | Q59095973 | ||
| Metabolism and function of human platelets washed by albumin density gradient separation | Q67584447 | ||
| Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: additional evidence in support of GPIb as a platelet receptor for von Willebrand factor | Q70237272 | ||
| Characterization of human platelet glycoprotein antigens giving rise to individual immunoprecipitates in crossed-immunoelectrophoresis | Q70559859 | ||
| Interaction of fibrinogen with its platelet receptor as part of a multistep reaction in ADP-induced platelet aggregation | Q71127880 | ||
| Participation of ADP in the binding of fibrinogen to thrombin-stimulated platelets | Q71291016 | ||
| An evaluation of membrane glycoproteins in platelet adhesion and aggregation | Q71519346 | ||
| The complex multimeric composition of factor VIII/von Willebrand factor | Q71545501 | ||
| Platelets, von Willebrand factor, and prostaglandin I2 | Q71555823 | ||
| Monoclonal antibody to human platelet glycoprotein I. II. Effects on human platelet function | Q71580688 | ||
| Use of monoclonal antibody to increase sensitivity and specificity in quantitative immunodiffusion assays | Q71585927 | ||
| Von Willebrand's disease | Q71646018 | ||
| Methods for the production of clinically effective intermediate- and high-purity factor-VIII concentrates | Q71793955 | ||
| Binding of radioiodinated human von Willebrand factor to Bernard-Soulier, thrombasthenic and von Willebrand's disease platelets | Q72082906 | ||
| Human platelet surface binding of endogenous secreted factor VIII-von Willebrand factor and platelet factor 4 | Q72099850 | ||
| Multimeric structure of platelet factor VIII/von Willebrand factor: the presence of larger multimers and their reassociation with thrombin-stimulated platelets | Q72115543 | ||
| Exposure of platelet fibrinogen-binding sites by collagen, arachidonic acid, and ADP: inhibition by a monoclonal antibody to the glycoprotein IIb-IIIa complex | Q72771425 | ||
| Induction of the fibrinogen receptor on human platelets by epinephrine and the combination of epinephrine and ADP | Q72868857 | ||
| Specific and saturable binding of plasma fibronectin to thrombin-stimulated human platelets | Q72909003 | ||
| Studies on apyrases | Q79075642 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1-12 | |
| P577 | publication date | 1983-07-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Platelets have more than one binding site for von Willebrand factor | |
| P478 | volume | 72 |
| Q55488560 | A monoclonal antibody binding to human medulloblastoma cells and to the platelet glycoprotein IIb-IIIa complex |
| Q40512752 | A monoclonal antibody recognizes a von Willebrand factor domain within the amino-terminal portion of the subunit that modulates the function of the glycoprotein IB- and IIB/IIIA-binding domains |
| Q34536168 | A monoclonal antibody to human platelet glycoprotein IIIa detects a related protein in cultured human endothelial cells |
| Q34518712 | A myeloma paraprotein with specificity for platelet glycoprotein IIIa in a patient with a fatal bleeding disorder |
| Q45171116 | A new model of dual interacting ligand binding sites on integrin alphaIIbbeta3. |
| Q34541247 | A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex |
| Q37093744 | A novel modifier gene for plasma von Willebrand factor level maps to distal mouse chromosome 11 |
| Q41931559 | A rare hemostatic disorder: pseudo von Willebrand's disease |
| Q92983692 | A rat model of severe VWD by elimination of the VWF gene using CRISPR/Cas9 |
| Q24338203 | ADAMTS13 substrate recognition of von Willebrand factor A2 domain |
| Q37562150 | ADP-dependent common receptor mechanism for binding of von Willebrand factor and fibrinogen to human platelets |
| Q43889368 | Activation of recombinant alphaIIbbeta3 expressed in Chinese hamster ovary cells exposes different binding sites for fibrinogen or von Willebrand factor: evidence using monoclonal antibodies to alphaIIbbeta3. |
| Q30479636 | Activation-independent platelet adhesion and aggregation under elevated shear stress |
| Q36407260 | Adhesive properties of the isolated amino-terminal domain of platelet glycoprotein Ibalpha in a flow field |
| Q73289093 | Adrenaline potentiates type 2B von Willebrand factor-induced activation of human platelets by enhancing both the formation and action of thromboxanes |
| Q34313515 | Agkistrodon piscivorus piscivorus platelet aggregation inhibitor: a potent inhibitor of platelet activation |
| Q24596704 | Amino acid sequence of the von Willebrand factor-binding domain of platelet membrane glycoprotein Ib |
| Q68043406 | An ultrastructural and immunohistochemical study of human dental pulp: identification of Weibel-Palade bodies and von Willebrand factor in pulp endothelial cells |
| Q39350686 | Application of microfluidic devices in studies of thrombosis and hemostasis |
| Q34521638 | Asialo von Willebrand factor interactions with platelets. Interdependence of glycoproteins Ib and IIb/IIIa for binding and aggregation |
| Q42860255 | Assignment of disulphide bonds in human platelet GPIIIa. A disulphide pattern for the beta-subunits of the integrin family |
| Q35593515 | Biogenesis of the platelet receptor for fibrinogen: evidence for separate precursors for glycoproteins IIb and IIIa |
| Q45246586 | Characterization of C3a receptor-proteins on guinea pig platelets and human polymorphonuclear leukocytes |
| Q74088680 | Characterization of the initial alpha-thrombin interaction with glycoprotein Ib alpha in relation to platelet activation |
| Q44139530 | Characterization of the unique mechanism mediating the shear-dependent binding of soluble von Willebrand factor to platelets |
| Q24316137 | Cloning of the murine platelet glycoprotein Ibalpha gene highlighting species-specific platelet adhesion |
| Q30499664 | Cochlin and glaucoma: a mini-review |
| Q36119792 | Cochlin in the eye: functional implications |
| Q34305447 | Combined blockade of ADP receptors and PI3-kinase p110β fully prevents platelet and leukocyte activation during hypothermic extracorporeal circulation |
| Q36256128 | Complementary roles for receptor clustering and conformational change in the adhesive and signaling functions of integrin alphaIIb beta3 |
| Q38359108 | Conformational changes in the A1 domain of von Willebrand factor modulating the interaction with platelet glycoprotein Ibalpha |
| Q44600729 | Crystal Structure of NMC-4 Fab anti-von Willebrand Factor A1 Domain |
| Q34260216 | Distinct abnormalities in the interaction of purified types IIA and IIB von Willebrand factor with the two platelet binding sites, glycoprotein complexes Ib-IX and IIb-IIIa |
| Q37377651 | Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions |
| Q41609653 | Distinct structural attributes regulating von Willebrand factor A1 domain interaction with platelet glycoprotein Ibalpha under flow |
| Q72069270 | Disulfide bond requirements for assembly of the platelet glycoprotein Ib-binding domain of von Willebrand factor |
| Q80955229 | Effect of swallowroot extract on functions of platelets in vitro |
| Q36028093 | Effects of in vivo modulation of splenic natural killer cell activity on the growth of spleen-seeking tumour variants |
| Q35585012 | Effects of monoclonal antibodies against the platelet glycoprotein IIb/IIIa complex on thrombosis and hemostasis in the baboon |
| Q34560030 | Epitope mapping of the von Willebrand factor subunit distinguishes fragments present in normal and type IIA von Willebrand disease from those generated by plasmin |
| Q28363214 | Evaluation of the role of proline residues flanking the RGD motif of dendroaspin, an inhibitior of platelet aggregation and cell adhesion |
| Q24292860 | Evidence that the primary binding site of von Willebrand factor that mediates platelet adhesion on subendothelium is not collagen |
| Q70201984 | Evidence that three adhesive proteins interact with a common recognition site on activated platelets |
| Q33899500 | Expression of the phenotypic abnormality of platelet-type von Willebrand disease in a recombinant glycoprotein Ib alpha fragment |
| Q34564820 | Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate |
| Q56601465 | Formation and regulation of platelet and fibrin hemostatic plug |
| Q67775135 | Function of glycoprotein Ib alpha in platelet activation induced by alpha-thrombin |
| Q34528200 | Functionally thrombasthenic state in normal platelets following the administration of ticlopidine |
| Q35003012 | G protein-dependent basal and evoked endothelial cell vWF secretion |
| Q30650321 | Genetic deletion of platelet glycoprotein Ib alpha but not its extracellular domain protects from atherosclerosis |
| Q34207017 | Glanzmann thrombasthenia resulting from a single amino acid substitution between the second and third calcium-binding domains of GPIIb. Role of the GPIIb amino terminus in integrin subunit association |
| Q24314966 | Identification of three tyrosine residues of glycoprotein Ib alpha with distinct roles in von Willebrand factor and alpha-thrombin binding |
| Q44971755 | Immunoelectron-microscopic studies of human platelet thrombospondin, von Willebrand factor, and fibrinogen redistribution during clot formation |
| Q35911430 | Impaired platelet aggregation and sustained bleeding in mice lacking the fibrinogen motif bound by integrin alpha IIb beta 3. |
| Q33446717 | Increased factor VIII/vWf levels in patients with reduced platelet number. |
| Q34565552 | Independent modulation of von Willebrand factor and fibrinogen binding to the platelet membrane glycoprotein IIb/IIIa complex as demonstrated by monoclonal antibody |
| Q24296142 | Inducible secretion of large, biologically potent von Willebrand factor multimers |
| Q67956784 | Influence of vasoactive substances on uremic bleeding in rats |
| Q46717216 | Inhibition of human platelet aggregation and membrane lipid peroxidation by food spice, saffron |
| Q37393216 | Inhibition of platelet function with synthetic peptides designed to be high-affinity antagonists of fibrinogen binding to platelets |
| Q24317407 | Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor |
| Q34624945 | Interaction of asialo von Willebrand factor with glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and mediates platelet aggregation |
| Q37554183 | Interaction of purified type IIB von Willebrand factor with the platelet membrane glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and initiates aggregation |
| Q34602783 | Interaction of von Willebrand factor with human platelets in the plasma milieu |
| Q71244316 | Isolated recombinant domain of von Willebrand factor displaying increased sensitivity to ristocetin |
| Q24314835 | Isolation of the thrombospondin membrane receptor |
| Q28216733 | Lateral clustering of platelet GP Ib-IX complexes leads to up-regulation of the adhesive function of integrin alpha IIbbeta 3 |
| Q38944642 | Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia A. |
| Q41481792 | Ligand binding and affinity modulation of integrins |
| Q35836105 | Localization of internal pools of membrane glycoproteins involved in platelet adhesive responses |
| Q41916499 | Mechanism of platelet adhesion to von Willebrand factor and microparticle formation under high shear stress |
| Q52675907 | Megakaryocyte ontogeny: Clinical and molecular significance. |
| Q37196287 | Microfluidic devices for studies of shear-dependent platelet adhesion |
| Q37912981 | Microvascular endothelial cell heterogeneity: interactions with leukocytes and tumor cells |
| Q30473382 | Molecular Imaging of Activated von Willebrand Factor to Detect High-Risk Atherosclerotic Phenotype |
| Q33400732 | Molecular characterization of the human platelet integrin GPIIb/IIIa and its constituent glycoproteins |
| Q47777127 | Multimerin: A Multimeric Protein Stored in Platelet Alpha-granules |
| Q44626034 | Multiple Epitope Specificity of Monoclonal Antibodies to a Single Synthetic Peptide: Use in the Characterization of the GP IIb-IIIa Binding Domain of Von Willebrand Factor |
| Q37715720 | Nonsense mutation in the glycoprotein Ib alpha coding sequence associated with Bernard-Soulier syndrome |
| Q44408524 | Novel effect of cyclicization of the Arg-Gly-Asp-containing peptide on vitronectin binding to platelets |
| Q40716742 | Old concepts and new developments in the study of platelet aggregation |
| Q63973106 | On the Mechanism of the Spermine-Exerted Inhibition on α-Thrombin-Induced Platelet Activation* |
| Q28609736 | On the association of glycoprotein Ib and actin-binding protein in human platelets |
| Q72270527 | Optimization of a recombinant von Willebrand factor fragment as an antagonist of the platelet glycoprotein Ib receptor |
| Q40999861 | Pathogenesis, clinical picture and treatment of von Willebrand's disease |
| Q45865145 | Plasma levels of active Von Willebrand factor are increased in patients with first ST-segment elevation myocardial infarction: a multicenter and multiethnic study. |
| Q36994814 | Plasminogen interacts with human platelets through two distinct mechanisms |
| Q34673739 | Platelet adhesion under flow |
| Q36838891 | Platelet adhesive dynamics. Part II: high shear-induced transient aggregation via GPIbalpha-vWF-GPIbalpha bridging |
| Q74551383 | Platelet aggregation in flow: differential roles for adhesive receptors and ligands |
| Q35584149 | Platelet glycoprotein IIb. Chromosomal localization and tissue expression |
| Q37406246 | Platelet glycoproteins IIb and IIIa: evidence for a family of immunologically and structurally related glycoproteins in mammalian cells |
| Q34986345 | Platelets in atherothrombosis |
| Q41975301 | Preferential antagonism of the interactions of the integrin alpha IIb beta 3 with immobilized glycoprotein ligands by snake-venom RGD (Arg-Gly-Asp) proteins. Evidence supporting a functional role for the amino acid residues flanking the tripeptide R |
| Q67528797 | Production and functional characterization of a recombinant fragment of von Willebrand factor (vWF): an antagonist to platelet receptor GP Ib |
| Q36902563 | Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men |
| Q36789903 | RGD induces conformational transition in purified platelet integrin GPIIb/IIIa-SDS system yielding multiple binding states for fibrinogen gamma-chain C-terminal peptide |
| Q43559368 | Regulation of von Willebrand factor binding to the platelet glycoprotein Ib-IX by a membrane skeleton-dependent inside-out signal |
| Q71995270 | Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice |
| Q57704398 | Reversible activation defect of the platelet glycoprotein IIb-IIIa complex in patients with uremia |
| Q37294912 | Role of fibrinogen alpha and gamma chain sites in platelet aggregation |
| Q47963220 | Role of the gamma chain Ala-Gly-Asp-Val and Aalpha chain Arg-Gly-Asp-Ser sites of fibrinogen in coaggregation of platelets and fibrinogen-coated beads |
| Q30479643 | Size regulation of von Willebrand factor-mediated platelet thrombi by ADAMTS13 in flowing blood |
| Q33927360 | Spontaneously occurring tumors of companion animals as models for human cancer |
| Q70221630 | Steroid hormone receptors |
| Q37346480 | Structure and function of von Willebrand factor: relationship to von Willebrand's disease |
| Q54595452 | Substitutions of proline 42 to alanine and methionine 46 to asparagine around the RGD domain of the neurotoxin dendroaspin alter its preferential antagonism to that resembling the disintegrin elegantin. |
| Q36607866 | Surface adhesins of Staphylococcus aureus |
| Q71843085 | Synergistic effect of epinephrine and shearing on platelet activation |
| Q36213082 | Synthesis by cultured human umbilical vein endothelial cells of two proteins structurally and immunologically related to platelet membrane glycoproteins IIb and IIIa |
| Q42254956 | Synthetic RGD peptides derived from the adhesive domains of snake-venom proteins: evaluation as inhibitors of platelet aggregation |
| Q74061144 | The AGDV residues on the gamma chain carboxyl terminus of platelet-bound fibrinogen are needed for platelet aggregation |
| Q41941084 | The integrin alpha IIb beta 3 contains distinct and interacting binding sites for snake-venom RGD (Arg-Gly-Asp) proteins. Evidence that the receptor-binding characteristics of snake-venom RGD proteins are related to the amino acid environment flanki |
| Q39591751 | The physiology and pathophysiology of the factor VIII complex |
| Q52013892 | The relationship of von Willebrand factor binding to activated platelets from healthy neonates and adults. |
| Q37604903 | The role of integrins in cancer and the development of anti-integrin therapeutic agents for cancer therapy. |
| Q43203872 | The role of the neutrophil and formed elements of the blood in an in vitro model of reperfusion injury |
| Q34182746 | The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress |
| Q53814684 | The von Willebrand factor-glycoprotein Ib/V/IX interaction induces actin polymerization and cytoskeletal reorganization in rolling platelets and glycoprotein Ib/V/IX-transfected cells. |
| Q35879197 | The yopM gene of Yersinia pestis encodes a released protein having homology with the human platelet surface protein GPIb alpha |
| Q37900072 | Thrombin generation in hemorrhage control and vascular occlusion |
| Q34774500 | Thrombin-dependent Incorporation of von Willebrand Factor into a Fibrin Network. |
| Q57791595 | Thrombosis and hemostasis in renal disease |
| Q33494457 | Thrombotic thrombocytopenic purpura: evidence that infusion rather than removal of plasma induces remission of the disease |
| Q37374506 | Truncation of the cytoplasmic domain of beta3 in a variant form of Glanzmann thrombasthenia abrogates signaling through the integrin alpha(IIb)beta3 complex |
| Q35577294 | Type IIB von Willebrand factor with normal sialic acid content induces platelet aggregation in the absence of ristocetin. Role of platelet activation, fibrinogen, and two distinct membrane receptors |
| Q34196324 | Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor. |
| Q24620409 | Variant Bernard-Soulier syndrome type bolzano. A congenital bleeding disorder due to a structural and functional abnormality of the platelet glycoprotein Ib-IX complex |
| Q36220351 | Von Willebrand factor promotes endothelial cell adhesion via an Arg-Gly-Asp-dependent mechanism |
| Q37194661 | Von Willebrand factor-binding protein is a hysteretic conformational activator of prothrombin |
| Q33444536 | Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor |
| Q35105786 | YopM inhibits platelet aggregation and is necessary for virulence of Yersinia pestis in mice |
| Q73118426 | [Blood coagulation, genetics and post-angioplasty restenosis] |
| Q67276057 | von Willebrand disease |
| Q70321843 | von Willebrand disease |
| Q37711736 | von Willebrand factor and platelet function |
| Q38687794 | von Willebrand factor and platelet function |
| Q33478102 | von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease |
| Q34574601 | von Willebrand factor interaction with the glycoprotein IIb/IIa complex. Its role in platelet function as demonstrated in patients with congenital afibrinogenemia |
| Q33899746 | von Willebrand factor mutation enhancing interaction with platelets in patients with normal multimeric structure |
| Q73690873 | von Willebrand factor stimulates thrombin-induced exposure of procoagulant phospholipids on the surface of fibrin-adherent platelets |
| Q34544068 | von Willebrand protein facilitates platelet incorporation in polymerizing fibrin |
Search more.